Revised Procedure for Reporting Blood Bank Activity

Beginning June 1, 2014, all licensed blood banks and transfusion services in Massachusetts will be required to report transfusion related adverse events using the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) Hemovigilance Module.

Important Information on using the CDC NHSN Hemovigilance Module.

#13-10-601 Revised Procedure for Reporting Blood Bank Activity – 11/8/2013 pdf format of Circular Letter #13-10-601
doc format of Circular Letter #13-10-601

Reporting transfusion related adverse events to NHSN DOES NOT replace reporting patient death or serious injury associated with unsafe administration of blood products as a Serious Reportable Event, 105 CMR 130.332(A) rtf format of 105cmr130.rtf
file size 1MB. Unsafe administration includes, but is not limited to, hemolytic reactions and administering: a) blood or blood products to the wrong patient; b) the wrong type; c) blood or blood products that have been improperly stored or handled.  All such events should be reported to the Clinical Laboratory Program within one business day at (617)753-8439 or 753-7307.


This information is provided by the Clinical Laboratory Program within the Department of Public Health.